Leczenie ubytków w przestrzeniach międzykorzeniowych wciąż stanowi duże wyzwanie, a mnogość czynników determinujących rezultaty kliniczne terapii jest powodem jej nieprzewidywalności.

Metoda tunelowa może być alternatywą stosowaną w przypadku leczenia zaawansowanych furkacji klasy II i III, których prognoza bez wdrożonego leczenia byłaby gorsza. Bardziej nowoczesne techniki sterowanej regeneracji tkanek dają dobre rezultaty kliniczne w przypadku prawidłowej kwalifikacji pacjentów, ale są wrażliwe na błędy proceduralne i obciążające ekonomicznie. Zastosowanie preparatu Emdogain może pozytywnie wpłynąć na wyniki zabiegów chirurgicznego leczenia zajętych przestrzeni międzykorzeniowych.

Celem pracy jest omówienie metody tunelowej i procedur z zakresu sterowanej regeneracji tkanek w leczeniu zajętych furkacji korzeni oraz rachunku zysków i strat wdrożonego leczenia na podstawie literatury przedmiotu.

Hasła indeksowe: ubytki w furkacjach korzeni, zapalenie przyzębia, metoda tunelowa, sterowana regeneracja tkanek, Emdogain

Treatment of cavities in the interradicular area is still a great challenge and the number of factors that determine the clinical results is the cause of their unpredictability.

The tunnel method may be an alternative used in the case of treating advanced Class II and III furcations, whose prognosis would be worse without treatment. More modern techniques of guided tissue regeneration give good clinical results in cases where the patient is properly qualified for treatment, but are sensitive to procedural mistakes and are an economic burden. Use of the preparation Emdogain may have a positive influence on the results of surgical treatment of the interradicular spaces.

The aim of the study was to discuss the tunnel method and procedures associated with guided tissue regeneration in treatment of involved root furcations and the plusses and minuses of the treatment on the basis of the literature.

 

Key words: cavities in root furcations, periodontal inflammation, tunnel method, guided tissue regeneration, Emdogain


PIŚMIENNICTWO
1. Huynh-Ba G. i wsp.: The effect of periodontal therapy on survival rate and incidence of complications of multirooted teeth with furcation involvement after an observation period of at least 5 years: a systematic review. J. Clin. Periodontol., 2008, 36, 2, 164-176.
2. Hamp S.E., Nyman S., Lindhe J.: Periodontal treatment of multirooted teeth. Results after 5 years. J. Clin. Periodontol., 1975, 2, 3, 126-135.
3. Tarnow D., Fletcher.: Classification of the vertical component of furcation involvement. J. Periodontol., 1984, 55, 5, 283-284.
4. Paolantonio M. i wsp.: Molar root furcation: morphometric and morphologic analysis. Int. J. Periodontics Restorative Dent., 1998, 18, 1, 489-501.
5. Hou G.L., Tsai C.C.: Types and dimensions of root trunk correlating with diagnosis of molar furcation involvement. J. Clin. Periodontol., 1997, 24, 2, 129-135.
6. Kerns D.G. i wsp.: Root trunk dimensions of 5 different tooth types. Int. J. Periodontics Restorative Dent., 1999, 19, 1, 83-91.
7. Chiu B.M. i wsp.: Periodontal implications of furcation entrance dimensions in Chineses first permanent molars. J. Periodontol., 1991, 62, 5, 308-311.
8. Helldén L.B. i wsp.: Prognosis of tunnel preparations in treatment of class III furcations. A follow-up study. J. Periodontol., 1989, 60, 11, 182-187.
9. Little L.A. i wsp.: Lack of furcal bone loss following the tunneling procedure. J. Clin. Periodontol., 1995, 22, 8, 637-641.
10. Rüdiger S.G.: Mandibular and maxillary furcation tunnel preparations –  literature review and a case report. J. Clin. Periodontol., 2001, 28, 1, 1-8.
11. Dannewitz B., Krieger J.K., Eickholz P.: Loss of molars in periodontally treated patients: a retrospective analysis after five years or more after active periodontal treatment. J. Clin. Periodontol., 2006, 33, 1, 53-61.
12. Zimmer S., Jahn K.R., Barthel C.R.: Recommendations for the use  of fluoride in caries prevention. Oral Health Prev. Dent., 2003, 1, 1, 45-51.
13. Niemann R.W. i wsp.: Dye ingress in molars: furcation to chamber floor. J. Endod., 1993, 19, 6, 293-296.
14. Bosshardt D.D., Sculean A.: Does periodontal tissue regeneration really works? Periodontol. 2000, 2009, 51, 1, 208-219.
15. Haghighati F., Saaveh G.: Essentials in periodontal regeneration. J. Dent., 2006, 4, 2, 78-88.
16. American Academy of Periodontology: Periodontal regeneration. J. Periodontol., 2005, 76, 9, 1601-1622.
17. Bashutski J.D., Wang H.L.: Periodontal and endodontic regeneration. J. Endod., 2009, 35, 3, 321-328.
18. Yukna R.A. i wsp.: Evaluation of durapatite ceramica as an alloplastic implant in periodontal osseous defects. II. Twelve-month reentry results. J. Periodontol., 1985, 56, 9, 540-547.
19. Pamela K., McClain P.K., Schallhorn R.G.: Focus on furcation defects-guided tissue regeneration in combination with bone grafting. Periodontol. 2000, 2000, 22, 1, 190-212.
20. Gottlow J. i wsp.: New attachment formation in human periodontium by GTR. Case reports. J. Clin. Periodontol., 1986, 13, 6, 604-616.
21. Yukna R.A., Yukna C.N.: Six-year clinical evaluation of HTR synthetic bone grafts in human grade II molar furcations. J. Periodontol. Res., 1997, 32, 8, 627-633.
22. Eickholz P., Hausmann E.: Evidence for healing of periodontal defects 5 years after conventional and regenerative therapy: digital subtraction and bone level measurements. J. Clin. Periodontol., 2002, 29, 10, 922-928.
23. Eickholz P. i wsp.: Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. III. Class II furcations after 10 years. J. Periodontol., 2006, 77, 1, 88-94.
24. Khanna D., Malhotra S., Naidu D.V.: Treatment of grade II furcation involvement using resorbable guided tissue regeneration membrane: a six-month study. J. Indian Soc. Periodontol., 2012, 16, 3, 404-410.
25. Houser B.E. i wsp.: Clinical evaluation of anorganic bovine bone xenograft with a bioabsorbable collagen barrier in the treatment of molar furcation defects. Int. J. Periodontics Restorative Dent., 2001, 21, 2, 161-169.
26. Lekovic V. i wsp.: Treatment of class II furcation defects using porous hydroxyapatite in conjunction with a polytetrafluoroethylene membrane. J. Periodontol., 1990, 61, 9, 575-578.
27. Anderegg C.R. i wsp.: Clinical evaluation of the use of decalcified freeze-dried bone allograft with guided tissue regeneration in the treatment of molar furcation invasions. J. Periodontol., 1991, 62, 4, 264-268.
28. Khashu H., Vandana K.L.: Clinical and radiographic evaluation of human periodontal osseous defect (mandibular grade II furcation) treated with PepGen P-15 and a bioresorbabale membrane (Atrisorb). J. Indian Soc. Periodontol., 2012, 16, 4, 569-576.
29. Andersson B. i wsp.: Treatment of furcation defects. Guided tissue regeneration versus coronally positioned flap in mandibular molars, a pilot study. J. Clin. Periodontol., 1994, 21, 3, 211-216.
30. Couri C.J. i wsp.: Medical grade calcium sulfate hemihydrate versus expanded polytetrafluoroethylene in the treatment of mandibular class II furcations. J. Periodontol., 2002, 73, 11, 1352-1359.
31. Cury P.R.: Long term results of guided tissue regeneration therapy in the treatment of class II furcation defects. J. Periodontol., 2003, 74, 1, 3-9.
32. Tsao Y.P. i wsp.: Effects of a mineralized human cancellous bone allograft in regeneration of mandibular class II furcation defects. J. Periodontol., 2006, 77, 3, 416-425.
33. Calongne K.B.: Clinical comparison of microporous biocompatible composite of PMMA, PHEMA and calcium hydroxide grafts and expanded polytetrafluoroethylene barrier membranes in human mandibular molar class II furcations. A case series. J. Periodontol., 2001, 72, 10, 1451-1459.
34. Metzler D.G. i wsp.: Clinical evaluation of guided tissue regeneration in the treatment of maxillary class II molar furcation invasions. J. Periodontol., 1991, 62, 6, 353-360.
35. Sanz M., Giovannoli J.L.: Focus on furcation defects: guided tissue regeneration. Periodontol. 2000, 2000, 22, 1, 169-189.
36. Palioto D.B.: Clinical and radiographic treatment evaluation class III furcation defects using GTR with and without inorganic bone matrix. J. Clin. Periodontol., 2003, 30, 1, 1-8.
37. Keila S. i wsp.: In vitro effects of enamel matrix proteins on rat bone marrow cells and gingival fibroblasts. J. Dent. Res., 2004, 83, 2, 134-138.
38. Galli C. i wsp.: Osteoprotegerin and receptor activator of nuclear factor-kappa B ligand modulation by enamel matrix derivative in human alveolar osteoblasts. J. Periodontol., 2006, 77, 7, 1223-1228.
39. Walter C. i wsp.: Moderate effect of enamel matrix derivative (Emdogain Gel) on Porphyromonas gingivalis growth in vitro. Arch. Oral Biol., 2006, 51, 3, 171-176.
40. Bosshardt D.D.: Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. J. Clin. Periodontol., 2008, 35, Suppl. 8, 87-105.
41. Pietruska M.D.: A comparative study on teh use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects. Eur. J. Oral Sci., 2001, 109, 3, 178-181.
42. Sculean A. i wsp.: Treatment of infrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study. J. Periodontol., 2006, 77, 11, 1879-1886.
43. Heden G., Wennstöm J.L.: Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. J. Periodontol., 2006, 77, 2, 295-301.
44. Trombelli L., Farina R.: Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. J. Clin. Periodontol., 2008, 35, Suppl. 8, 117-135.
45. Chitsazi M.T. i wsp.: Efficacy of open flap debridement with and without enamel matrix derivatives in the treatment  of mandibular degree II furcation involvement. Clin. Oral Investig., 2007, 11, 4, 385-389.
46. Jepsen S. i wsp.: A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part I: study design and results for primary outcomes. J. Periodontol., 2004, 75, 9, 1150-1160.
47. Meyle J. i wsp.: A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part II: secondary outcomes. J. Periodontol., 2004, 75, 9, 1188-1195.
48. Hoffmann T. i wsp.: A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part III: patient factors and treatment outcome. J. Clin. Periodontol., 2006, 33, 8, 575-583.
49. Jaiswal R., Deo V.: Evaluation of the effectiveness of enamel matrix derivative, bone grafts, and membranes in the treatment of mandibular Class II furcation defects. Int. J. Periodontics Restorative Dent., 2013, 33, e58-604. doi: 10.11607/prd.1428.
50. Donos N. i wsp.: Clinical evaluation of an enamel matrix derivative in the treatment of mandibular degree II furcation involvement: a 36-month case series. Int. J. Periodontics Restorative Dent., 2003, 23, 5, 507-512.
51. Casarin R.C. i wsp.: Influence of anatomic features on the effectiveness of enamel matrix derivative proteins in the treatment of proximal Class II furcation involvements. Quintessence Int., 2009, 40, 9, 753-761.
52. Casarin R.C. i wsp.: A double-blind randomized clinical evaluation of enamel matrix derivative proteins for the treatment of proximal class-II furcation involvements. J. Clin. Periodontol., 2008, 35, 5, 429-437.
53. Casarin R.C. i wsp.: Enamel matrix derivative proteins for the treatment of proximal class furcation involvements: a prospective 24-month randomized clinical trial. J. Clin. Periodontol., 2010, 37, 12, 1100-1109.
54. Donos N. i wsp.: Clinical evaluation of an enamel matrix derivative and a bioresorbable membrane in the treatment of degree III mandibular furcation involvement: a series of nine patients. Int. J. Periodontics Restorative Dent., 2004, 24, 4, 362-369.